Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

TP53 mutations in breast cancer: association with ductal histology and early relapse of disease.

The International journal of biological markers - 1 Jan 2000

Brankovic-Magic M V, Jankovic R N, Dobricic J D, Borojevic N D, Magic Z M, Radulovic S S

Abstract excerpt

PURPOSE: This study aimed to investigate the incidence of core domain TP53 mutations in Serbian breast cancer patients in view of their possible correlation with prognostic parameters, tumor characteristics and clinical disease course. METHODS: 145 breast cancer patients were included. Data on clinical disease course were available for 100 patients including 30 node-negative and 70 node-positive patients. After...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Disease-Free Survival

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genes, p53

Share to Polymorphism, Single-Stranded Conformational

Share to Receptors, Steroid

Share to Recurrence

Share to Serbia

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 18949740
DOI: 10.1177/172460080802300303

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

TP53 mutations in breast cancer: association with ductal histology and early relapse of disease.PMID 18949740Read ↗

TP53 mutation spectrum in breast cancer is subtype specific and has distinct prognostic relevance.Semantic proximity Read ↗

TP53Mutation is an Independent Prognostic Marker for Poor Outcome in Both Node-negative and Node-positive Breast CancerSemantic proximity Read ↗

Heterogeneity in the clinical phenotype of TP53 mutations in breast cancer patients.Semantic proximity Read ↗

Predictive and prognostic role of p53 according to tumor phenotype in breast cancer patients treated with preoperative chemotherapy: a single-institution analysis.Semantic proximity Read ↗

Role of TP53 mutations in triple negative and HER2-positive breast cancer treated with neoadjuvant anthracycline/taxane-based chemotherapy.Semantic proximity Read ↗

Germline TP53 Testing in Breast Cancers: Why, When and How?Semantic proximity Read ↗

p53 in breast cancer subtypes and new insights into response to chemotherapy.Semantic proximity Read ↗

Influence of mutation type on prognostic and predictive values of TP53 status in primary breast cancer patients.Semantic proximity Read ↗

Prognostic and predictive value of TP53mutations in node-positive breast cancer patients treated with anthracycline- or anthracycline/taxane-based adjuvant therapy: results from the BIG 02-98 phase III trialSemantic proximity Read ↗

Mutations in residues of TP53 that directly contact DNA predict poor outcome in human primary breast cancer.Semantic proximity Read ↗

Only Missense Mutations Affecting the DNA Binding Domain of P53 Influence Outcomes in Patients with Breast CarcinomaSemantic proximity Read ↗

Cytoplasmic p53β Isoforms Are Associated with Worse Disease-Free Survival in Breast Cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.